IEZZI, MANUELA
 Distribuzione geografica
Continente #
NA - Nord America 8.156
AS - Asia 4.852
EU - Europa 4.795
SA - Sud America 688
Continente sconosciuto - Info sul continente non disponibili 586
AF - Africa 98
OC - Oceania 10
Totale 19.185
Nazione #
US - Stati Uniti d'America 7.972
SG - Singapore 1.954
CN - Cina 1.267
IT - Italia 931
IE - Irlanda 713
UA - Ucraina 611
BR - Brasile 553
RU - Federazione Russa 504
SE - Svezia 494
TR - Turchia 494
VN - Vietnam 465
GB - Regno Unito 452
DE - Germania 343
IN - India 330
FR - Francia 296
FI - Finlandia 162
CA - Canada 95
HK - Hong Kong 78
NL - Olanda 65
AR - Argentina 53
PL - Polonia 47
BD - Bangladesh 44
MX - Messico 42
ZA - Sudafrica 42
CZ - Repubblica Ceca 39
BE - Belgio 32
IQ - Iraq 32
ES - Italia 25
JP - Giappone 25
AT - Austria 24
VE - Venezuela 22
KR - Corea 20
EC - Ecuador 16
IR - Iran 16
PK - Pakistan 16
SA - Arabia Saudita 16
CO - Colombia 14
ID - Indonesia 14
MA - Marocco 13
EU - Europa 12
AE - Emirati Arabi Uniti 11
IL - Israele 11
CH - Svizzera 10
CL - Cile 10
KE - Kenya 10
RO - Romania 10
CR - Costa Rica 9
JM - Giamaica 9
EG - Egitto 8
GR - Grecia 8
PH - Filippine 8
AU - Australia 7
BG - Bulgaria 7
MY - Malesia 7
OM - Oman 7
PY - Paraguay 7
TT - Trinidad e Tobago 7
UZ - Uzbekistan 7
PE - Perù 6
TN - Tunisia 6
LT - Lituania 5
PT - Portogallo 5
UY - Uruguay 5
AO - Angola 4
AZ - Azerbaigian 4
BZ - Belize 4
HN - Honduras 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
DZ - Algeria 3
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
BS - Bahamas 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
PR - Porto Rico 2
RS - Serbia 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
BM - Bermuda 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
LC - Santa Lucia 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 18.604
Città #
Singapore 1.468
San Jose 910
Chandler 897
Jacksonville 704
Dublin 703
Ashburn 520
Beijing 365
Council Bluffs 312
Dallas 303
Princeton 300
Southend 286
Dearborn 233
Izmir 225
Nanjing 188
New York 187
Santa Clara 170
Los Angeles 166
Ann Arbor 156
Ho Chi Minh City 150
Altamura 134
Wilmington 134
Chieti 127
The Dalles 112
Cambridge 111
Pescara 102
Boardman 98
Hanoi 91
Tongling 78
Hong Kong 72
Buffalo 66
São Paulo 66
Nanchang 63
Munich 62
Moscow 56
Redondo Beach 56
Woodbridge 50
Orem 42
Phoenix 41
Columbus 39
Warsaw 39
Brooklyn 38
Denver 38
Helsinki 36
Montreal 36
Chicago 34
Hebei 34
Atlanta 33
Grevenbroich 33
Johannesburg 33
Washington 33
Tianjin 32
Chennai 31
Dong Ket 31
Nuremberg 31
Rome 31
Frankfurt am Main 30
Seattle 30
Houston 29
Shenyang 29
Brno 28
London 28
Milan 27
Hefei 26
Amsterdam 24
Brussels 24
Kunming 24
Tokyo 24
Norwalk 23
Ancona 21
Changsha 21
Mexico City 21
Toronto 21
Augusta 20
Haiphong 20
Poplar 20
Rio de Janeiro 20
San Francisco 20
Seoul 20
Ankara 19
Da Nang 19
Turku 19
Hangzhou 18
Jiaxing 18
Manchester 18
Boston 17
Stockholm 17
Baghdad 16
Castignano 16
Jinan 16
San Mateo 16
Mumbai 15
Vienna 15
Charlotte 14
Lappeenranta 14
Orange 14
Pune 14
Falls Church 13
Guangzhou 13
St Louis 13
Belo Horizonte 12
Totale 11.282
Nome #
Resveratrol has anti-thyroid effects both in vitro and in vivo 390
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 220
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 203
L’allergoide monomerico agisce anche sul GALT 188
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 186
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 175
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 175
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 173
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 168
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 167
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 166
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 163
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 162
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 159
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 159
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 158
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 158
Anti-Thyroid Effect of Resveratrol 157
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 157
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 154
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 154
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 153
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 151
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 147
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 147
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 145
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 145
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 144
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 144
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 144
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 143
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 142
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 142
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 141
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 141
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 139
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 138
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 137
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 136
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 136
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 136
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 135
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 135
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 135
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 134
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 134
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 134
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 133
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 133
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 133
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 133
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 132
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 132
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 131
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 131
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 130
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 130
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 130
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 128
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 128
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 126
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 126
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 125
null 125
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. 124
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 123
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 123
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 123
3D-informed targeting of the Trop-2 signal-activation site drives selective cancer vulnerability 122
Neutrophils in anti-cancer immunological strategies: old players in new games 122
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 121
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 120
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 120
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 120
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 120
Antimetastatic activity of a preventive cancer vaccine. 119
p130Cas is an essential transducer element in ErbB2 transformation. 119
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 119
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 117
Stem Cell Emergence After HBO In Volunteers 117
Generation of multiparametric MRI maps by using Gd-labelled-RBCs reveals phenotypes and stages of murine prostate cancer 117
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 117
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 117
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 115
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 115
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 115
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 115
rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant. 114
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 113
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 113
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 112
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 112
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 111
Phospholipase Cgamma1 is required for metastasis development and progression 111
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 109
Multiorgan Metastasis of Human HER-2(+) Breast Cancer in Rag2(-/-);Il2rg(-/-) Mice and Treatment with PI3K Inhibitor. 109
Arginase 1-based immune modulatory vaccines induce anti-cancer immunity and synergize with anti-PD-1 checkpoint blockade 109
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 108
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 108
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages 107
Totale 13.832
Categoria #
all - tutte 77.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022680 0 0 14 120 53 12 26 60 55 50 83 207
2022/20232.468 184 362 156 280 272 471 127 168 285 32 63 68
2023/20241.158 78 54 68 51 61 346 270 66 14 28 13 109
2024/20252.929 173 490 388 102 94 136 205 194 294 130 325 398
2025/20266.211 491 257 574 786 651 416 1.077 360 656 542 268 133
2026/2027831 277 410 144 0 0 0 0 0 0 0 0 0
Totale 19.185